Sci Adv

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.

Skendros P, Germanidis G, Mastellos DC, ..., Ritis K, Lambris JD

Sci Adv 8 (33) eabo2341 [2022-08-19; online 2022-08-17]

Category: Biochemistry Category: Health Type: Journal article

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies.

Hanke L, Sheward DJ, Pankow A, ..., McInerney GM, Murrell B

Sci Adv 8 (12) eabm0220 [2022-03-25; online 2022-03-25]

Category: Biochemistry Category: Health Funder: H2020 Funder: VR Type: Journal article

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app.

Sudre CH, Lee KA, Lochlainn MN, ..., Steves CJ, Ourselin S

Sci Adv 7 (12) - [2021-03-00; online 2021-03-19]

Category: Public Health Type: Journal article

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.

Stebbing J, Sánchez Nievas G, Falcone M, ..., Abizanda P, Lauschke VM

Sci Adv 7 (1) - [2020-11-13; online 2020-11-13]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Host cell systems biology and targets Type: Journal article

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.

Panda PK, Arul MN, Patel P, ..., Suar M, Ahuja R

Sci Adv 6 (28) eabb8097 [2020-07-00; online 2020-07-10]

Category: Biochemistry Category: Imaging Funder: VR Type: Journal article